A detailed history of Deka Bank Deutsche Girozentrale transactions in Arvinas, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 42,000 shares of ARVN stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,000
Previous 42,000 -0.0%
Holding current value
$1.12 Million
Previous $1.74 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$14.19 - $42.33 $312,180 - $931,260
22,000 Added 110.0%
42,000 $1.76 Million
Q1 2023

Apr 24, 2023

SELL
$26.15 - $37.26 $282,420 - $402,408
-10,800 Reduced 35.06%
20,000 $536,000
Q1 2022

Apr 28, 2022

BUY
$60.27 - $81.57 $66,297 - $89,726
1,100 Added 3.7%
30,800 $1.97 Million
Q4 2021

Feb 02, 2022

BUY
$65.85 - $96.21 $563,017 - $822,595
8,550 Added 40.43%
29,700 $2.37 Million
Q1 2021

Apr 28, 2021

BUY
$58.19 - $91.37 $98,923 - $155,329
1,700 Added 8.74%
21,150 $1.32 Million
Q4 2020

Mar 12, 2021

SELL
$20.19 - $84.93 $402,790 - $1.69 Million
-19,950 Reduced 50.63%
19,450 $1.57 Million
Q3 2020

Oct 29, 2020

BUY
$22.99 - $36.34 $905,805 - $1.43 Million
39,400 New
39,400 $926,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.42B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.